Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-17-002051

Director acquired 2,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Fust Matthew K · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2017-01-03 Grant or award : show line 1 in the form +2,000 19,093 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2017-01-03 Grant or award : show line 2 in the form Non-Qualified Stock Option (Right to Buy) +5,500 $15.08 2024-01-03 5,500 5,500 D
Loading xslF345X03/doc4.xml…